Kaufman & Broad SA
Kaufman & Broad SA: AGM 6, May 2021 results
20-May-2021 / 09:55 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
COMBINED ORDINARY AND EXTRAORDINARY
SHAREHOLDERS' MEETING
MAY 6, 2021
Number of shareholders present or reprensented to the meeting :
|
372
|
Number of shareholder shares present or represented to the meeting :
|
18,042,479
|
Number of shareholder votes present or reprensented to the meeting :
|
22,256,952
|
|
|
GENERAL QUORUM reached
|
|
|
Resolutions
|
Result
|
Votes cast
|
Exclusions
|
For
|
Against
|
Forbearance
|
(in number and proportion
|
(in number and proportion
|
(in number and proportion
|
(in number and proportion
|
(in number and proportion
|
of votes
|
of votes
|
of votes
|
of votes
|
of votes
|
cast)
|
cast)
|
cast)
|
cast)
|
cast)
|
|
|
|
|
|
|
|
|
RESOLUTIONS SUBMITTED TO ORDINARY SHAREHOLDERS' MEETING
|
1.
|
Review and approval of the statutory financial statements for the fiscal year ended November 30, 2020
|
Adopted
|
22,256,952
|
-
|
22,239,308
|
540
|
17,104
|
83.10%
|
|
99.998%
|
0.002%
|
0.077%
|
2.
|
Appropriation of earnings for the fiscal year ended November 30, 2020
|
Adopted
|
22,256,952
|
-
|
22,215,275
|
41,540
|
37
|
83.10%
|
|
99.81%
|
0.19%
|
0.00%
|
3.
|
Examination and approval of the consolidated financial statements for the fiscal year ended November 30, 2020
|
Adopted
|
22,256,952
|
-
|
22,239,308
|
540
|
17,104
|
83.10%
|
|
99.998%
|
0.002%
|
0.077%
|
4.
|
Review and approval of agreements referred to in Article L. 225-38 of the Commercial Code
|
Adopted
|
22,256,952
|
-
|
22,224,110
|
540
|
37
|
83.10%
|
|
100.00%
|
0.00%
|
0.00%
|
5.
|
Approval of the compensation policy for the Chairman and Chief Executive Officer
|
Adopted
|
22,206,452
|
50,000
|
22,046,453
|
159,045
|
1,454
|
82.86%
|
0.23%
|
99.28%
|
0.72%
|
0.01%
|
6.
|
Approval of the remuneration policy for directors
|
Adopted
|
22,256,452
|
500
|
22,198,640
|
57,219
|
593
|
83.09%
|
0.00%
|
99.74%
|
0.26%
|
0.00%
|
7.
|
Approval of fixed, variable and exceptional items making up the total compensation and benefits of any kind paid during the fiscal year ended November 30, 2020 or allocated for the same fiscal year to the Chairman - Chief Executive Officer
|
Adopted
|
22,206,952
|
50,000
|
20,900,426
|
1,217,348
|
89,180
|
82.86%
|
0.00%
|
94.50%
|
5.50%
|
0.40%
|
8.
|
Approval of the information mentioned in Article L.22-10-9 -I of the Commercial Code
|
Adopted
|
22,256,952
|
-
|
22,224,087
|
32,828
|
37
|
83.10.%
|
|
99.85%
|
0.15%
|
0.00%
|
9.
|
Recognition of the expiration of the term of office of Mr. Nordine HACHEMI, renewal of the term of office of Mr. Nordine HACHEMI for a period of three years
|
Adopted
|
22,256,952
|
-
|
20,998,776
|
1,588,139
|
37
|
83.10%
|
|
92.87%
|
7.14%
|
0.00%
|
10.
|
Recognition of the expiration of the director mandate of Mr. André MARTINEZ, appointment of a new director for a period of three years
|
Adopted
|
22,256,952
|
-
|
22,170,970
|
85,880
|
102
|
83.10%
|
|
99.61%
|
0.37%
|
0.00%
|
11.
|
Recognition of the expiration of the term of office of Mrs. Sylvie CHARLES, renewal of the term of office of Mrs. Sylvie CHARLES for a period of three years
|
Adopted
|
22,256,952
|
-
|
22,181,760
|
75,155
|
37
|
83.10%
|
|
99.66%
|
0.34%
|
0.00%
|
12.
|
Recognition of the expiration of the term of office of Mrs. Sophie LOMBARD, renewal of the term of office of Mrs. Sophie LOMBARD for a period of three years
|
Adopted
|
22,256,952
|
-
|
21,990,057
|
266,858
|
37
|
83.10%
|
|
98.80%
|
1.20%
|
0.00%
|
13.
|
Recognition of the expiration of the term of office of Mrs. Lucile RIBOT, renewal of the term of office of Mrs. Lucile RIBOT for a period of three years
|
Adopted
|
22,256,952
|
-
|
22,238,216
|
18,699
|
37
|
|
|
|
83.10%
|
|
99.92%
|
0.08%
|
0.00%
|
14.
|
Recognition of the expiration of the mandate of director representing the employee shareholders of Mrs. Karine NORMAND, renewal of the mandate of director of Mrs. Karine NORMAND for a period of three years
|
Adopted
|
22,256,952
|
-
|
22,237,292
|
18,699
|
1,051
|
83.10%
|
|
99.92%
|
0.08%
|
0.00%
|
15.
|
Recognition of the expiration of the term of office as director of Mrs. Caroline PUECHOULTRES, appointment of a new director for a period of three years
|
Adopted
|
22,256,952
|
-
|
22,140,078
|
116,837
|
37
|
83.10%
|
|
99.48%
|
0.53%
|
0.00%
|
16.
|
Recognition of the expiration of the terms of office of ERNST & YOUNG AUDIT, statutory auditor of the Company and of AUDITEX, deputy auditor of the Company; appointment of statutory auditors for a period of six fiscal years
|
Adopted
|
22,256,952
|
-
|
20,107,516
|
2,149,399
|
37
|
83.10%
|
|
90.34%
|
9.66%
|
0.00%
|
17.
|
Recognition of the expiration of the mandates of DELOITTE & ASSOCIES, statutory auditor of the Company and of B.E.A.S., deputy auditor of the Company; appointment of statutory auditors for a period of six fiscal years
|
Adopted
|
22,256,952
|
-
|
22,244,175
|
12,740
|
37
|
83.10%
|
|
99.94%
|
0.06%
|
0.00%
|
18.
|
Authorization to be granted to the board of directors, for a period of eighteen months, for the purpose of purchasing by the company its own shares
|
Adopted
|
22,256,952
|
-
|
22,205,810
|
20,661
|
30,481
|
83.10%
|
|
99.91%
|
0.09%
|
0,14%
|
31.
|
Powers for completing formalities
|
Adopted
|
22,256,952
|
-
|
22,256,377
|
540
|
35
|
|
83.10%
|
|
100.00%
|
0.00%
|
0.00%
|
RESOLUTIONS SUBMITTED TO EXTRAORDINARY SHAREHOLDERS' MEETING
|
19.
|
Authorization to be granted to the board of directors, for a period of twenty-six months, for the purpose of canceling shares held by the Company following the repurchase of its own shares
|
Adopted
|
22 256 952
|
-
|
22,255,296
|
1,619
|
37
|
83,10%
|
|
10.00%
|
0.00%
|
0.00%
|
20.
|
Delegation of authority to be granted to the board of directors, for a period of twenty-six months, for the purpose of increasing the share capital by incorporation of reserves or premiums
|
Adopted
|
22 256 952
|
-
|
22,256,375
|
540
|
37
|
83,10%
|
|
100.00%
|
0.00%
|
0.00%
|
21.
|
Delegation of authority to be granted to the board of directors, for a period of twenty-six months, for the purpose of issuing ordinary shares and / or equity securities giving access to other equity securities or giving the right to the allocation of debt securities and / or marketable securities giving access to equity securities to be issued by the Company with maintenance of shareholders' preferential subscription rights
|
Adopted
|
22 256 952
|
-
|
21,171,112
|
85,803
|
37
|
83,10%
|
|
9.61%
|
0.39%
|
0.00%
|
22.
|
Delegation of authority to be granted to the board of directors, for a period of twenty-six months, for the purpose of issuing ordinary shares and / or equity securities giving access to other equity securities or giving the right to the allocation of debt securities and / or marketable securities giving access to equity securities to be issued by the Company, with cancellation of shareholders' preferential subscription rights, within the framework of public offers other than those referred to in l Article L.411-2 of the Monetary and Financial Code
|
Adopted
|
22 256 952
|
-
|
21,603,813
|
653,813
|
37
|
83,10%
|
|
97.06%
|
2.94%
|
0.00%
|
23.
|
Delegation of authority to be granted to the board of directors, for a period of twenty-six months, for the purpose of issuing ordinary shares, and / or equity securities giving access to other equity securities or giving rights to the allocation of debt securities, and / or marketable securities giving access to equity securities to be issued by the Company, with cancellation of shareholders' preferential subscription rights, within the framework of public offers referred to in 1 of Article L.411-2 of the Monetary and Financial Code
|
Adopted
|
22 256 952
|
|
21,098,191
|
1,158,724
|
37
|
83,10%
|
|
94.80%
|
5.21%
|
0.00%
|
24.
|
Authorization to be granted to the board of directors, for a period of twenty-six months, in the event of the issue of ordinary shares, and / or equity securities giving access to other equity securities or giving right to the allocation of debt securities, and / or marketable securities giving access to equity securities to be issued by the Company with cancellation of shareholders' preferential subscription rights, to set the issue price according to the terms set by the general meeting within the limit of 10% of the share capital
|
Adopted
|
22 256 952
|
-
|
21,052,836
|
1,204,079
|
37
|
83,10%
|
|
94.60%
|
5.41%
|
0.00%
|
25.
|
Authorization to be granted to the board of directors, for a period of twenty-six months, in order to increase the number of securities to be issued in the event of a capital increase with maintenance or with elimination of shareholders' preferential subscription rights
|
Adopted
|
22 256 952
|
-
|
21,044,163
|
1,212,752
|
37
|
83,10%
|
|
94.45%
|
5.45%
|
0.00%
|
26.
|
Delegation of authority to be granted to the board of directors, for a period of twenty-six months, for the purpose of issuing shares or equity securities giving access to other equity securities or giving the right to the allocation debt securities as remuneration for contributions in kind of equity securities or marketable securities giving access to the capital within the limit of 10% of the share capital
|
Adopted
|
22 256 952
|
-
|
22,131,859
|
123,066
|
37
|
83,10%
|
|
99.44%
|
0.56%
|
0.00%
|
27.
|
Delegation of authority to be granted to the board of directors, for a period of twenty-six months, for the purpose of issuing shares and / or equity securities giving access to other equity securities or to the allocation debt securities as remuneration for securities contributed to any public exchange offer initiated by the Company
|
rejected
|
22 256 952
|
-
|
14,168,813
|
8,088,102
|
37
|
83,10%
|
|
63.66%
|
36.34%
|
0.00%
|
28.
|
Delegation of authority to be granted to the board of directors, for a period of twenty-six months, for the purpose of issuing shares and / or securities giving access to the Company's shares to be issued with cancellation of the preferential subscription right of shareholders, for the benefit of members of the group's Company Savings Plan (s) for an amount of 3% of the capital
|
Adopted
|
22 256 952
|
-
|
22,131,871
|
125,044
|
37
|
83,10%
|
|
99.44%
|
0.56%
|
0.00%
|
29.
|
Authorization to be granted to the board of directors, for a period of thirty-eight months, for the purpose of allocating free shares to be issued or existing for the benefit of employees and / or executive corporate officers of the Company and related entities
|
Adopted
|
22 256 952
|
-
|
21,589,949
|
579,240
|
87,763
|
83,10%
|
|
97.39%
|
2.61%
|
0.39%
|
30.
|
Setting of the general ceilings for delegations of authority at a nominal amount of (i) € 2,270,000 for all capital increases through the issue of shares or equity securities giving access to other equity securities or securities giving access to equity securities to be issued, (ii) € 568,000 for capital increases through the issue of shares or equity securities giving access to other equity securities or securities securities giving access to equity securities to be issued with cancellation of preferential subscription rights and (iii) € 500,000,000, for issues of debt securities giving the right to the allocation of a capital or debt security; setting specific ceilings for capital increases likely to result from the allocation of free shares
|
Adopted
|
22 256 952
|
|
22,129,522
|
127,393
|
37
|
83,10%
|
-
|
99.43%
|
0.57%
|
0.00%
|
This press release is available at www.kaufmanbroad.fr
Contacts
About Kaufman & Broad - Kaufman & Broad has been designing, developing, building, and selling single-family homes in communities, apartments, and offices on behalf of third parties for more than 50 years. Kaufman & Broad is one of the leading French developers-builders due to the combination of its size and profitability, and the strength of its brand.
The Kaufman & Broad Registration Document was filed with the French Financial Markets Authority ("AMF") under No. 21-0239 on March 31, 2021. It is available on the AMF (www.amf-france.org) and Kaufman & Broad (www.kaufmanbroad.fr) websites. It contains a detailed description of Kaufman & Broad's business activities, results, and outlook, as well as the associated risk factors. Kaufman & Broad specifically draws attention to the risk factors set out in Chapter 4 of the Registration Document. The occurrence of one or more of these risks might have a material adverse impact on the Kaufman & Broad.
Regulatory filing PDF file
File: AGM 6, May 2021 results
|